Evidence map›Paper›PMID 22470386›Full record

ArticleNephron extra2011

Aquaporin-2 promoter is synergistically regulated by nitric oxide and nuclear factor of activated T cells.

María F Albertoni Borghese, Layne M Bettini, Carlos H Nitta, Sergio de Frutos, Mónica Majowicz, Laura V Gonzalez Bosc

Open access · goldAbstract read
In one paragraph

Article in Nephron extra, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Arginase-II negatively regulates renal aquaporin-2 and water reabsorption.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

María F Albertoni BorgheseBiología Celular y Molecular, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Layne M Bettini
Carlos H Nitta
Sergio de Frutos
Mónica Majowicz
Laura V Gonzalez Bosc
University of New Mexico · USUniversity of Buenos Aires · AR

Funding

NFATc3 in chronic hypoxic pulmonary hypertensionR01HL088151 · NHLBI · UNIVERSITY OF NEW MEXICO · PI GONZALEZ BOSC, LAURA V · 2008 to 2012
$2.0M
NHLBI NIH HHS R01 HL088151
6 · The paper itself

Abstract

BACKGROUND/

aimsWe have previously shown that aquaporin-2 (AQP2) is down-regulated in the renal medulla of rats made hypertensive by chronic inhibition of nitric oxide synthase. It has been shown that AQP2 expression is regulated by the calcineurin/nuclear factor of activated T cells (NFATc). Nitric oxide (NO) regulates the activity of NFATc via c-Jun-N-terminal kinase 2 (JNK2). Therefore, we hypothesized that increases in NO enhance NFATc-mediated up-regulation of AQP2 promoter activity.

methodsAQP2 mRNA and protein expression were detected in mouse renal papilla. AQP2 promoter luciferase reporter- and NFAT luciferase reporter-transfected MDCK cells were used to determine AQP2 promoter activity and NFATc activity, respectively. Cells were incubated with classic activators and inhibitors of NFATc and the NO pathway.

resultsOur results demonstrate that both Ca(2+) and NO have a synergistic effect resulting in an increase in AQP2 mRNA and protein in mouse papilla and activation of the AQP2 promoter in kidney-derived cells. In addition, NO enhances Ca(2+)-induced NFATc activation. The underlying mechanism involves increased NFATc nuclear import and decreased export via protein kinase G-mediated inhibition of JNK1/2.

conclusionsThis is the first study defining novel regulatory roles for NO and NFATc in the control of AQP2, which is an important renal protein.

Indexed as

AQP2MDCK cellsNFATcNitric oxideNuclear factorRenal papilla

Identifiers

PMID22470386
PMCPMC3290856
OpenAlexW1985505018

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.